Self-destructive and self-protective processes in the damaged optic nerve: Implications for glaucoma

Investigative Ophthalmology and Visual Science

Volumn 41, Issue 2, 2000, Pages 349-351

  Schwartz, Michal ^a   Yoles, Eti ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROTROPIN;

APOPTOSIS; CELL DEGENERATION; CELL REGENERATION; GLAUCOMA; INTRAOCULAR PRESSURE; OPTIC NERVE LESION; PRIORITY JOURNAL; RETINA GANGLION CELL; RISK FACTOR; SHORT SURVEY; TISSUE INJURY;

ANIMALS; APOPTOSIS; AXONS; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; NERVE DEGENERATION; OPTIC DISK; RETINAL GANGLION CELLS;

EID: 0033952686     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (19)

1. Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol. 1994;112:37-44.
2. Schwartz M, Belkin M, Yoles E, Solomon A. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration. J Glaucoma. 1996;5:427-432.
3. Dreyer EB. A proposed role for excitotoxicity in glaucoma. J Glaucoma. 1998;7:62-67.
4. Osborne NN, Ugarte M, Chao M, et al. Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surr Ophthalmol. 1999;43(Suppl 1):S102-S128.
5. Quigley HA. Neuronal death in glaucoma. Prog Retina Eye Res. 1999;18:39-57.
6. Neufeld AH. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surr Ophthalmol. 1999;43(Suppl 1): S129-S135.
7. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114:299-305.
8. Brooks DE, Garcia GA, Dreyer EB, Zurakowski D, Franco-Bourland RE, Vitreous body glutamate concentration in dogs with glaucoma. Am J Vet Res. 1997;58:864-867.
9. Yoles E, Schwartz M. Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve. Arch Ophthalmol. 1998;116:906-910.
10. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci USA. 1999;96:9944-9948.
11. Voles E, Schwartz M. Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp Neurol. 1998;153:1-7.
12. Schwartz M, Yoles E. Subtoxic levels of glutamate increase resistance to toxic levels in the rat retina [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1999;40(4):S763. Abstract nr 4030.
13. Isenmann S, Bahr M. Expression of c-Jun protein in degenerating retinal ganglion cells after optic nerve lesion in the rat. Exp Neurol. 1997;147:28-36.
14. Vecino E, Ugarte M, Nash MS, Osborne NN. NMDA induces BDNF expression in the albino rat retina in vivo. Neuroreport. 1999;10: 1103-1106.
15. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med. 1999;5:49-55.
16. Schwartz M, Moalem G, Leibowitz-Amit R, Cohen IR. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999;22:295-299.
17. Popovich PG, Whitacre CC, Stokes BT. Is spinal cord injury an autoimmune disease? Neuroscientist. 1998;4:71-76.
18. Ehrhard PB, Erb P, Graumann U, Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc Natl Acad Sci USA. 1993;90:10984-10988.
19. Santambrogio L, Benedetti M, Chao MV, et al. Nerve growth factor production by lymphocytes. J Immunol. 1994;153: 4488-4495.